Streetbeat News

Products Services

AMGN

Amgen announced that its experimental obesity drug does not affect bone mineral density, addressing concerns that had previously led to a 7% drop in its stock price.

Portfolio Pulse from

November 13, 2024 | 10:45 am

MPU

Mega Matrix Inc. has launched a new romantic short drama, 'Spoiled by My CEO Husband', on FlexTV. The drama, released on November 13, 2024, explores themes of romance and societal prejudices.

Portfolio Pulse from

November 13, 2024 | 10:45 am

PLTR

Palantir, an artificial intelligence company, is experiencing growth with enterprises, presenting a significant opportunity for expansion.

Portfolio Pulse from

November 13, 2024 | 10:45 am

MTCH

Match Group, the owner of Tinder and Hinge, is currently perceived as a potentially undervalued stock. Investors are debating whether it represents a generational buying opportunity or a value trap.

Portfolio Pulse from

November 13, 2024 | 10:45 am

QCOM

Viettel has launched the world's first O-RAN 5G network using Qualcomm's 5G RAN platforms, marking a significant milestone in telecommunications technology.

Portfolio Pulse from

November 13, 2024 | 10:45 am

NVDA

Nvidia's chips will be utilized in SoftBank's supercomputer, highlighting Nvidia's dominance in advanced AI hardware. Despite this positive development, Nvidia's stock experienced a slight decline.

Portfolio Pulse from

November 13, 2024 | 10:45 am

INFY

Infosys Knowledge Institute's CMO Radar 2024 report reveals that 73% of enterprises have implemented AI, including generative AI, in marketing, with 52% seeing business value. AI-fluent CMOs are increasingly influential in corporate decisions, enhancing brand experience and marketing efficiency.

Portfolio Pulse from

November 13, 2024 | 10:30 am

DUOL

The article highlights a language education platform that is expanding its use of artificial intelligence, suggesting it as a strong investment opportunity for 2025.

Portfolio Pulse from

November 13, 2024 | 10:30 am

INTC

Intel is facing challenges in gaining market share in the semiconductor industry, which is crucial for the US economy as it aims to become a leading chip manufacturer.

Portfolio Pulse from

November 13, 2024 | 10:15 am

AMGN

Amgen released a statement regarding the Phase 1 data of MariTide, a drug formerly known as AMG 133. This update is significant for investors as it pertains to the development of Amgen's pharmaceutical pipeline.

Portfolio Pulse from

November 13, 2024 | 10:15 am